Navigation path


Confronting EC Colloquium on Neglected Protozoan Diseases EC Conference on neglected protozoan diseases

Please click on image to enlarge and see details

Friday, 24 September 2010, Institute Pasteur, Paris, FRANCE

09.00 - Registration and Poster Set-up / Welcome

09.30 - Prof. Anthony Pugsley(109kb), Scientific Director of the Institute Pasteur

09.45 - Anna Lnnroth(223kb), Health Research, DG RTD, European Commission

Session 1: New tools for controlling Protozoan Diseases

Chair : Gerald Spth

10.00 - Solomon Nwaka(4.7MB), TDR, Geneva - Fighting Protozoan Diseases: global perspectives and new initiatives

10.20 - Jean-Claude Dujardin(1.1MB), ITM, Antwerpen, Belgium - New tools for monitoring drug resistance and treatment response in visceral leishmaniasis (Kaladrug-R)

10.40 - Michael Miles(3.2MB), LSHTM, London, UK - Comparative epidemiology of genetic lineages of Trypanosoma cruzi (Chagas EpiNet)

11.00 - Coffee Break and poster session

Session 2: Vaccines for Leishmaniasis

Chair : Anna Lnnroth

11.30 - Steve Reed(1.2MB), IDRI, Seattle, USA - Development of Next Generation Vaccines for Leishmaniasis

11.50 - Paul Kaye, Univ York, UK - Developing vaccines for visceral leishmaniasis : "Doubt is not a pleasant condition, but certainty is absurd"

12.10 - Grard Marie Papierok(740kb), Virbac SA, La Seyne sur mer, France - PSA-based human vaccine candidate targeting visceral, cutaneous and mucocutaneous leishmaniasis (Rapsodi)

12.30 - Farrokh Modabber(2.2MB), DNDi, Geneva and LSHTM, London, UK - Development of a DNA vaccine for visceral leishmaniasis (LeishDNAvax)

12.50 - Lunch buffet and poster session

Session 3: Innovative Drug Discovery for Neglected Infectious Diseases

Chair : Jean-Claude Dujardin

14.30 - Manica Balasegaram(782kb), DNDi, Geneva, Switzerland - New developments for neglected diseases: an update of DNDi activities

14.50 - Michael Barrett(3.6MB), Univ of Glasgow, UK - Innovative drug discovery for human African trypanosomiasis

15.10 - Gerald Spth(2.8MB), Institute Pasteur, Paris, France - Targeting the Leishmania kinome for the development of novel anti-parasitic strategies (LeishDrug)

15.30 - Helge B. Bode(6.2MB), Frankfurt University, Frankfurt, Germany - Genomic approaches to metabolite exploitation from Xenorhabdus/Photorhabdus (GAMEXP)

15.50 - Dolores Gonzlez Pacanowska(528kb), Granada, Spain - Nucleobase derivatives as drugs against trypanosomal diseases (Trypobase)

16.10 - Coffee Break and poster session

Session 4: Diagnostics and Biomarkers for Neglected Protozoan Diseases

Chair : Stefan Magez

16.30 - Joseph Ndung'u(1.3MB), FIND, Geneva, Switzerland - New diagnostics for neglected protozoan diseases

16.50 - Krister Kristensson(5.5MB), Karolinska Institut, Stockholm, Sweden - African trypanosomes: how do they enter the brain and cause sleeping sickness

17.10 - Christine Clayton(527kb), ZMBH, Heidelberg, Germany - Transcriptomic approaches to understanding trypanosomes in culture and in the host

17.30 - Stefan Magez(4.4MB), Flanders Inst. Biotechnology, Gent, Belgium - Development of new tools to control infections due to parasites of the Trypanosomatidae family (Nanotryp)

17.50 - Closure followed by poster session and dinner buffet (ends at 22.00)

Abstract book

Dowload PDF(1.4MB)